Novartis Institutes for BioMedical Research
250 Mass Avenue
15 articles with Novartis Institutes for BioMedical Research
Vicinitas launched with a Series A round worth $65 million and was co-led by a16z and Deerfield Management, with participants including Droia Ventures, GV, and the Berkeley Catalyst Fund.
A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later.
Orna, which began as an academic query at the Massachusetts Institute of Technology (MIT), is a biotechnology company creating fully engineered circular RNA, or O-shaped RNA therapies for the treatment of cancer, autoimmune, and genetic disorders.
Astellas Venture Management, Pitango Venture Capital and Novartis Institutes for BioMedical Research Lead TScan Series B
Total Series B Raise of $35 million
SciBite Gathers 'Clean Data' Inspired Life Science Leaders at US-based Customer Meeting
SciBite, the award-winning semantic technology company, last week hosted its annual US-based customer meeting at Novartis Institutes for BioMedical Research in Boston, MA, sparking 'clean data' discussions.
Navitor Appoints New CEO
8/3/2018Navitor Pharmaceuticals, headquartered in Cambridge, Massachusetts, announced that Thomas E. Hughes will be the company’s new chief executive officer.
The Novartis Institutes for BioMedical Research (NIBR) is ending its early-stage anti-infectives research programs located in Emeryville, California. As a result, the company expects to lay off about 140 employees.
Educational institutions, even at the high school level, are creating specialized biotechnology training programs to satisfy the growth they see within the biotech industry.
Novartis has found its new chief of oncology.
The company said the Breakthrough Therapy Designation is based on positive results from the Phase III MONALEESA-7 trial.
The scientist was among the nearly one dozen people injured on Oct. 31.
Novartis Institutes for BioMedical Research Cambridge Campus Wins Special Recognition In Lab Of The Year Awards
Ash Stevens Honors Cancer Research Award Winner - James E. Bradner, MD, Novartis Institutes for BioMedical Research
Drug-Resistant Melanoma Tumors Shrink When Therapy Is Interrupted, University of California, San Francisco (UCSF), Novartis Institutes for BioMedical Research, and University Hospital Zurich Study
Novartis Pharma AG Moves Into Old Necco Candy Factory; Sugar Will Again Be Crucial